VU534
VU534 is a dual-action small molecule that acts as a NAPE-PLD agonist (EC50 = 0.30 μM) and inhibits both FAAH and soluble epoxide hydrolase (sEH IC50 = 1.2 μM) . Its modulation of lipid signaling pathways makes it a valuable research tool for in vitro and in vivo studies in cardiometabolic disease research.
Product Specifications
CAS Number
923509-20-0
Product Name Alternative
PLD, Epoxide Hydrolase, EpoxideHydrolase, FAAH, sEH, VU 534, VU534, VU-534
Field of Research
Metabolism Research, Neuroscience
Purity
98.85% (May vary between batches)
Solubility
DMSO:6.25 mg/mL (13.96 mM)
Smiles
CC1=CC2=C (SC (NC (=O) C3CCN (CC3) S (=O) (=O) C3=CC=C (F) C=C3) =N2) C (C) =C1
Molecular Formula
C21H22FN3O3S2
Molecular Weight
447.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
15862141 1x 10^6 Cells / 1.0 mL
CELSR2 CRISPR Knock Out 293T Cell Line (Human)
Sign In for Pricing
View Details 
bs-19138R-PerCP-Cy5.5 100 µL
ZFY19 Polyclonal Antibody, PerCP-Cy5.5 Conjugated
Sign In for Pricing
View Details MBS1104508-01 0.02 mg (E-Coli)
Recombinant Streptomyces griseus subsp. griseus D-ribose pyranase 1 (rbsD1)
Sign In for Pricing
View Details